Introduction {#sec1}
============

Well-recognized variants of eosinophilic folliculitis (EF), also known as *eosinophilic* *pustular folliculitis*, include Ofuji disease, infantile EF, and HIV-associated EF, which is considered a defining illness of AIDS.

A fourth less commonly recognized subtype of EF is that associated with hematologic malignancy, in particular leukemia and non-Hodgkin lymphoma (NHL).[@bib1] EF in HIV-negative individuals and associated with hematologic malignancy was first reported in 1993.[@bib2] This variant of EF may be underrecognized and difficult to diagnose given the clinical scenario, morphology, and variable histologic findings, detailed in a series of 3 patients with EF in association with chronic lymphocytic leukemia (CLL) presented herein.

Case series {#sec2}
===========

Patient 1 {#sec2.1}
---------

A 69-year-old man with a history of CLL, and undergoing chemotherapy with fludarabine, cyclophosphamide, and rituximab, presented with a 2-week history of a highly pruritic eruption distributed over the scalp, face, neck, upper trunk, and extremities. Physical examination found scattered excoriated papules and vesicles ([Fig 1](#fig1){ref-type="fig"}, *A*). Complete blood count with differential found a peripheral eosinophilia of 10% (350/mm^3^, with total white blood cell \[WBC\] count of 3500/mm^3^). The initial clinical diagnoses considered were disseminated varicella-zoster virus infection and drug eruption; the initial histologic diagnosis rendered was papular urticaria. Skin biopsy found papillary dermal edema overlying a wedge-shaped lymphocytic infiltrate with numerous eosinophils ([Fig 2](#fig2){ref-type="fig"}, *A*); step sections showed focal involvement of the follicular infundibulum and sebaceous lobule ([Fig 2](#fig2){ref-type="fig"}, *B*). The eruption resolved after a 2-week course of prednisone but later recurred followed by gradual resolution over the course of several weeks.Fig 1**A**, Patient 1: Excoriated papulovesicles over the ear, neck, and cheek. **B**, Patient 2: Excoriated papules, some with urticarial morphology, on the chest and arms.Fig 2**A**, Patient 1: Florid dermal eosinophilia and perivascular lymphocytic infiltrate, simulating features of arthropod bite reaction. **B**, Eosinophils, spongiosis, and mucin within the folliculosebaceous unit. (**A** and **B**, Hematoxylin-eosin stain; original magnifications: **A** and **B**, ×200.)

Patient 2 {#sec2.2}
---------

A 75-year-old man with a history of CLL and recent chemotherapy with chlorambucil presented with a 1-month history of pruritic papulovesicles and urticarial papules distributed over the head, neck, chest, back, and arms ([Fig 1](#fig1){ref-type="fig"}, *B*). The initial clinical diagnoses considered were drug eruption and arthropod bite reaction; the initial histologic diagnosis rendered was arthropod bite reaction. Skin biopsy found superficial and deep perivascular mixed infiltrates with abundant eosinophils and infundibular vesiculation with eosinophils and follicular mucin. Marked improvement with near clearance of lesions was noted after treatment with isotretinoin (1 mg/kg/d) for 1 month.

Patient 3 {#sec2.3}
---------

A 51-year-old man with a history of CLL and concurrent chemotherapy with fludarabine, cyclophosphamide, and rituximab, presented with a 6-week history of pruritic papules, vesicles, and rare plaques, distributed over the face with prominent involvement of the cheeks, ears, and forehead, as well as upper trunk and arms. Complete blood count with differential found a peripheral eosinophilia of 7% (343/mm^3^, with total WBC count of 4900/mm^3^). Initial skin biopsy found typical arthropod bite reaction, with a wedge-shape lymphocytic infiltrate with numerous eosinophils. Of note, this initial specimen lacked prominent follicular involvement. A repeat biopsy showed findings similar to those noted in patients 1 and 2. Follicular spongiosis and vesiculation with surrounding dermal edema and rare eosinophils within the folliculosebaceous unit were identified on step sections. Resolution of lesions was gradual over several months without specific treatment. Clinicopathologic characteristics of patients with EF associated with CLL are summarized in [Table I](#tbl1){ref-type="table"}.Table IClinicopathologic features of EF associated with CLL[@bib3], [@bib4], [@bib5]Age, ySexUnderlying hematologic malignancyTreatment for malignancyPeripheral eosinophiliaClinical descriptionDistributionClinical differential diagnosisNotable histologic featuresInitial histologic diagnosisTreatment and clinical course69[∗](#tbl1fnlowast){ref-type="table-fn"}MCLLChemotherapy (fludarabine, cyclophosphamide, and rituximab)10% (350/mm^3^, with total WBC count 3500/mm^3^)Papules, vesicles and urticarial plaquesHead and neck, trunk, armsDisseminated VZV infection; drug eruptionEosinophils within sebaceous lobule and follicular infundibulumPapular urticariaPrednisone; recurrence then resolution over several weeks75[∗](#tbl1fnlowast){ref-type="table-fn"}MCLLChemotherapy (chlorambucil)N/APapules, vesicles and pustulesHead and neck, trunk, armsDrug eruption; insect bite reactionMarked infundibular spongiosis with eosinophils and mucinInsect bite reactionNear clearance with isotretinoin51[∗](#tbl1fnlowast){ref-type="table-fn"}MCLLChemotherapy (fludarabine, cyclophosphamide, and rituximab)7% (343/mm^3^, with total WBC count 4900/mm^3^)Papules, vesicles and plaquesFace, upper trunk, armsLeukemia cutisSpongiosis and eosinophils within folliculo-sebaceous unitInsect bite reactionGradual resolution without specific treatment47[†](#tbl1fndagger){ref-type="table-fn"}FCLLChemotherapyN/AN/AN/AN/AN/AN/AN/A52[†](#tbl1fndagger){ref-type="table-fn"}MCLLChemotherapyN/AN/AN/AN/AN/AN/AN/A61[†](#tbl1fndagger){ref-type="table-fn"}MCLLChemotherapyN/APruritic follicular papules and pustulesFace, neck, and chestN/ANumerous eosinophils, lymphocytes and neutrophils within pilosebaceous unitsN/AN/A53[†](#tbl1fndagger){ref-type="table-fn"}MCLLN/A770/mm^3^Pruritic papules, vesicles, and pustules with crustingFace, scalp, neck, arms, backN/AIntrafollicular eosinophilic pustulesN/AInitial treatment with isotretinoin ineffective; eventual outcome N/A[^1][^2][^3]

Discussion {#sec3}
==========

The first subtype of EF described was Ofuji\'s disease, characterized as a papulopustular eruption in Asians, with formation of coalescent plaques and distributed over the cheeks, upper trunk, and upper extremities. In contrast, infantile EF favors the scalp of young males and recurs in crops of sterile pustules with eventual spontaneous remission. A third described subtype of EF is HIV associated and is an AIDS-defining illness that typically presents with urticarial papules and plaques on the head, neck, and upper trunk. Paradoxically, pustules are usually absent in the HIV-associated subtype. All forms of EF are associated with marked pruritus and may demonstrate an associated peripheral eosinophilia.[@bib6] Importantly, histologic findings are variable and may depend on the stage of disease at the time of biopsy. Peri-infundibular lymphocytic infiltrates with variable numbers of eosinophils are seen early while infundibular spongiosis, vesiculation, and pustule formation with infiltration of folliculosebaceous units by eosinophils is seen when lesions are more well established.[@bib1] Treatments with variable reported efficacies include indomethacin, topical and systemic steroids, phototherapy, isotretinoin, and, if HIV associated, highly active antiretroviral therapy. In patients with underlying hematologic malignancy, resolution with minimal specific treatment is typical, occurring after 8 weeks.[@bib1], [@bib7]

Before this series of 3 patients, 4 patients with EF in association with CLL were reported in the English-language literature. Including this series, 6 of 7 patients have been men older than 50 years. Six of 7 patients have developed EF during or after the administration of chemotherapy. In all cases in which the clinical morphology and distribution of lesions were reported (5 of 7), pruritic papules with variable vesicles, pustules, and urticarial lesions occurred on the head and neck, upper trunk, and arms. Furthermore, in all patients with reported histopathology (5 of 7), eosinophils within some portion of the folliculosebaceous unit were demonstrated.[@bib3], [@bib4], [@bib5]

Within this series, peripheral blood eosinophilia was present in 2 of 3 cases for which the results of complete blood count with differential were available. Of note, EF was not considered within the initial clinical or histopathologic differential diagnosis ([Table I](#tbl1){ref-type="table"}). In all 3 patients, the initial histopathologic diagnosis was either arthropod bite reaction or papular urticaria, based on the common finding of a superficial and deep perivascular lymphocytic infiltrate with numerous eosinophils. Repeat biopsy, review of initial specimens, and step sections for the diagnostic finding of eosinophils within the folliculosebaceous unit, in conjunction with clinicopathologic correlation, ultimately permitted accurate diagnosis. Elected treatments were varied, but gradual resolution was observed in the 3 patients.

Patients presenting with EF in association with a variety of other hematologic malignancies, such as NHL (including mantle cell lymphoma, diffuse B-cell lymphoma, and splenic marginal zone lymphoma), Hodgkin lymphoma, acute and chronic myeloid leukemias, acute lymphoblastic leukemia, multiple myeloma and Waldenstrom macroglobulinemia, and Sézary syndrome, have been reported ([Table II](#tbl2){ref-type="table"}). Uniformly reported clinicopathologic features include pruritic papules above the waist and perifollicular or intrafollicular eosinophils. Age and sex, peripheral eosinophilia, and the presence of polymorphous lesions including vesicles, papules, or urticarial lesions are variable ([Table II](#tbl2){ref-type="table"}). Additionally, the occurrence of EF after chemotherapy, bone marrow transplantation (BMT), or stem cell transplantation (SCT) is a commonly reported feature.[@bib1], [@bib2], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15]Table IIClinicopathologic features of EF associated with underlying hematologic malignancy other than CLLStudyAge, ySexUnderlying hematologic malignancyTreatment for malignancyPeripheral eosinophiliaClinical descriptionDistributionNotable histologic featuresTakamura et al[@bib6]77MMantle cell lymphomaChemotherapy13%Pruritic, erythematous papulesFace, neckEosinophils around follicles and sebaceous glandsTakamura et al[@bib6]60MMantle cell lymphomaChemotherapy3.7%Pruritic, follicular reddish papulesFaceEosinophils around follicles and sebaceous glandsBhandare et al[@bib8]64FSplenic marginal zone lymphomaChemotherapy2968/mL^3^Pruritic, follicular papules and pustulesScalp, back, proximal extremitiesFollicular spongiosis with eosinophilsZitelli et al[@bib1]56MAcute lymphoblastic leukemiaAutologous SCT6.4%Pruritic papules and pustulesFace, chest, and backIntrafollicular collections of eosinophilsSugaya et al[@bib9]42MSézary syndromeN/A9.5%Pruritic reddish follicular papulesCheeksProminent follicular exocytosis of eosinophilsRashid et al[@bib10]74MChronic myelomonocytic leukemiaChemotherapyN/APruritic perifollicular papulesNeck and chestPerifollicular infiltrates with eosinophils, follicular mucinGoiriz et al[@bib7]25FAcute eosinophilic leukemiaAllogeneic peripheral blood SCT8.6%Pruritic follicular papulesAxillae and trunkIntrafollicular eosinophil collections, spongiosis and crustingKeida et al[@bib11]41MDiffuse large B-cell lymphomaAutologous peripheral blood SCT12.5%Pruritic reddish follicular papules and pustulesUpper trunkFollicular exocytosis of eosinophils and neutrophilsOta et al[@bib12]22FChronic myelogenous leukemiaAllogeneic BMT800 × 10^6^/LPruritic red papules, coalescent erythemaFace and scalpEosinophilic infiltrates within follicles and sebaceous glandsPatrizi et al[@bib4]45MAcute monocytic leukemiaNoneN/APruritic follicular papules and pustules, urticarial lesionsFace, neck, shoulders, axillaeNumerous eosinophils, lymphocytes and neutrophils within pilosebaceous unitsVassallo et al[@bib13]25FHodgkin lymphomaChemotherapy1%Pruritic follicular papules and pustulesScalp and thighsEosinophilic exocytosis into all segments of follicle and sebaceous glandEvans et al[@bib14]35MDiffuse B-cell NHL, intermediate typeAutologous BMT21.6%Pruritic papules and pustulesFace, scalp, and trunkEosinophil-rich pustules within follicular epitheliumBull et al[@bib2]59MMultiple myelomaChemotherapy and autologous BMT18%Pruritic urticarial papulesFace, upper trunk, and armsProminent intrafollicular eosinophilsBull et al[@bib2]39FAcute erythroid leukemiaChemotherapy and allogeneic BMT424 × 10^6^/LPruritic papulesForehead and cheeksFollicular degeneration with perivascular eosinophilsBull et al[@bib2]40MAcute myeloid leukemiaChemotherapy and autologous BMT8%Pruritic papules and pustulesShoulders and thighsNumerous perifollicular eosinophilsBull et al[@bib2]76MWaldenstrom macroglobulinemiaChemotherapy3.2%Pruritic papulesUpper backProminent eosinophils within the follicular infundibulumPatrizi et al[@bib15]31FDiffuse B-cell NHLChemotherapy and autologous BMT12%Pruritic follicular papules and pustulesForehead and cheeksFollicular spongiosis and perivascular eosinophils[^4]

Of note, a condition termed *eosinophilic dermatosis of hematologic* malignancy has also been described in the literature, with striking clinicopathologic overlap with the cases described in this series in terms of morphology, distribution, context of underlying lymphoproliferative disorder (including CLL), perifollicular and intrafollicular eosinophilia, and natural history.[@bib16] Thus, it is likely that eosinophilic dermatosis of hematologic malignancy represents the same entity described herein---EF.

Although the pathogenesis of EF is not well understood, one potential immunologic pathway in patients with underlying hematologic malignancy is the clonal expansion of T helper 2, cells which produce interleukin-5, resulting in the stimulation of eosinophils.[@bib4], [@bib13] Degranulation of perifollicular mast cells may also recruit eosinophils to the follicular epithelium.[@bib2] Given the temporal relationship to chemotherapy, BMT, or SCT, EF in the context of hematologic malignancy may also represent a hypersensitivity to *Demodex* or *Malassezia* species.[@bib13]

EF should be included in the clinical and histopathologic differential diagnosis when evaluating a patient with underlying hematologic malignancy presenting with a pruritic papulovesicular, pustular, or urticarial eruption above the waist. In patients with CLL, male sex, age older than 50 years, distribution of lesions over the head and neck and upper trunk, peripheral eosinophilia, and occurrence during or after chemotherapy are common clinical features that may help dermatologists consider EF in the differential diagnosis.[@bib3], [@bib4], [@bib5] Furthermore, within this series, it was observed that a frequent initial histopathologic consideration was arthropod bite reaction/papular urticaria, and clinicopathologic correlation in tandem with careful search for eosinophils within the folliculosebaceous unit was essential for accurate diagnosis of this uncommon entity.
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[^1]: *CLL*, Chronic lymphocytic leukemia; *EF*, eosinophilic folliculitis; *F*, female; *M*, male; *N/A*, not available; *VZV*, varicella-zoster virus.

[^2]: Reported within this series.

[^3]: Previously reported in the literature.

[^4]: *BMT*, Bone marrow transplantation; *CLL*, chronic lymphocytic leukemia; *EF*, eosinophilic folliculitis; *F*, female; *M*, male; *N/A*, not available; *NHL*, non-Hodgkin lymphoma; *SCT*, stem cell transplantation.
